We are looking for adult participants with uncontrolled moderate to severe asthma with a diagnosis of asthma, aged 19-75.
The trial is recruiting participants who:
- Have uncontrolled moderate to severe asthma, and
- Are currently using a medium- or high-dose combination steroid/bronchodilator inhaler but continue to experience symptoms or exacerbations.
Individuals currently taking GLP-1–based medications such as Ozempic, Wegovy, Mounjaro, or Zepbound are not eligible for participation.
Participation is voluntary and confidential. You will be compensated for your time and travel.













